194 related articles for article (PubMed ID: 15642492)
1. Effects of prolonged in vitro exposure to sulphonylureas on the function and survival of human islets.
Del Guerra S; Marselli L; Lupi R; Boggi U; Mosca F; Benzi L; Del Prato S; Marchetti P
J Diabetes Complications; 2005; 19(1):60-4. PubMed ID: 15642492
[TBL] [Abstract][Full Text] [Related]
2. The non-peptidyl low molecular weight radical scavenger IAC protects human pancreatic islets from lipotoxicity.
D'Aleo V; Del Guerra S; Martano M; Bonamassa B; Canistro D; Soleti A; Valgimigli L; Paolini M; Filipponi F; Boggi U; Del Prato S; Lupi R
Mol Cell Endocrinol; 2009 Oct; 309(1-2):63-6. PubMed ID: 19481137
[TBL] [Abstract][Full Text] [Related]
3. Insulin exocytosis in Goto-Kakizaki rat beta-cells subjected to long-term glinide or sulfonylurea treatment.
Kawai J; Ohara-Imaizumi M; Nakamichi Y; Okamura T; Akimoto Y; Matsushima S; Aoyagi K; Kawakami H; Watanabe T; Watada H; Kawamori R; Nagamatsu S
Biochem J; 2008 May; 412(1):93-101. PubMed ID: 18254725
[TBL] [Abstract][Full Text] [Related]
4. Sulfonylurea induced beta-cell apoptosis in cultured human islets.
Maedler K; Carr RD; Bosco D; Zuellig RA; Berney T; Donath MY
J Clin Endocrinol Metab; 2005 Jan; 90(1):501-6. PubMed ID: 15483097
[TBL] [Abstract][Full Text] [Related]
5. Effects of fructosamine-3-kinase deficiency on function and survival of mouse pancreatic islets after prolonged culture in high glucose or ribose concentrations.
Pascal SM; Veiga-da-Cunha M; Gilon P; Van Schaftingen E; Jonas JC
Am J Physiol Endocrinol Metab; 2010 Mar; 298(3):E586-96. PubMed ID: 20009024
[TBL] [Abstract][Full Text] [Related]
6. Improved human pancreatic islet isolation for a prospective cohort study of islet transplantation vs best medical therapy in type 1 diabetes mellitus.
Warnock GL; Meloche RM; Thompson D; Shapiro RJ; Fung M; Ao Z; Ho S; He Z; Dai LJ; Young L; Blackburn L; Kozak S; Kim PT; Al-Adra D; Johnson JD; Liao YH; Elliott T; Verchere CB
Arch Surg; 2005 Aug; 140(8):735-44. PubMed ID: 16103282
[TBL] [Abstract][Full Text] [Related]
7. Direct effects of rapid-acting insulin analogues on insulin signaling in human pancreatic islets in vitro.
D'Aleo V; Mancarella R; Del Guerra S; Boggi U; Filipponi F; Marchetti P; Lupi R
Diabetes Metab; 2011 Sep; 37(4):324-9. PubMed ID: 21354844
[TBL] [Abstract][Full Text] [Related]
8. Differential effect of sulfonylureas on production of reactive oxygen species and apoptosis in cultured pancreatic beta-cell line, MIN6.
Sawada F; Inoguchi T; Tsubouchi H; Sasaki S; Fujii M; Maeda Y; Morinaga H; Nomura M; Kobayashi K; Takayanagi R
Metabolism; 2008 Aug; 57(8):1038-45. PubMed ID: 18640379
[TBL] [Abstract][Full Text] [Related]
9. The influence of cultivation on (pro-)insulin biosynthesis and secretion of isolated pancreatic islets of C57BL-mice, long-term treated with glibenclamide in vivo.
Wilke B; Ziegler B; Schmidt S; Woltanski P; Zühlke H
Endokrinologie; 1980 Dec; 76(3):357-64. PubMed ID: 6781881
[TBL] [Abstract][Full Text] [Related]
10. Sustained enhancement of Ca(2+) influx by glibenclamide induces apoptosis in RINm5F cells.
Iwakura T; Fujimoto S; Kagimoto S; Inada A; Kubota A; Someya Y; Ihara Y; Yamada Y; Seino Y
Biochem Biophys Res Commun; 2000 May; 271(2):422-8. PubMed ID: 10799313
[TBL] [Abstract][Full Text] [Related]
11. Hyaluronidase-induced inhibition of the insulinotropic action of sulfonylureas, leucine, and glucagon in rodent isolated pancreatic islets.
Macchi IA; Zeytinoğlu FN
Horm Metab Res; 1976 Mar; 8(2):92-6. PubMed ID: 177348
[TBL] [Abstract][Full Text] [Related]
12. Alterations of insulin secretion from mouse islets treated with sulphonylureas: perturbations of Ca2+ regulation prevail over changes in insulin content.
Anello M; Gilon P; Henquin JC
Br J Pharmacol; 1999 Aug; 127(8):1883-91. PubMed ID: 10482920
[TBL] [Abstract][Full Text] [Related]
13. Sulphonylureas do not increase insulin secretion by a mechanism other than a rise in cytoplasmic Ca2+ in pancreatic B-cells.
Garcia-Barrado MJ; Jonas JC; Gilon P; Henquin JC
Eur J Pharmacol; 1996 Mar; 298(3):279-86. PubMed ID: 8846827
[TBL] [Abstract][Full Text] [Related]
14. Effects of glimepiride and glyburide on glucose counterregulation and recovery from hypoglycemia.
Szoke E; Gosmanov NR; Sinkin JC; Nihalani A; Fender AB; Cryer PE; Meyer C; Gerich JE
Metabolism; 2006 Jan; 55(1):78-83. PubMed ID: 16324923
[TBL] [Abstract][Full Text] [Related]
15. Effects of sulphonylureas on the volume-sensitive anion channel in rat pancreatic beta-cells.
Best L; Benington S
Br J Pharmacol; 1998 Oct; 125(4):874-8. PubMed ID: 9831927
[TBL] [Abstract][Full Text] [Related]
16. Desensitization of sulphonylurea- and nutrient-induced insulin secretion following prolonged treatment with glibenclamide.
Ball AJ; Flatt PR; McClenaghan NH
Eur J Pharmacol; 2000 Nov; 408(3):327-33. PubMed ID: 11090651
[TBL] [Abstract][Full Text] [Related]
17. Glibenclamide but not other sulphonylureas stimulates release of neuropeptide Y from perifused rat islets and hamster insulinoma cells.
Kulkarni RN; Wang ZL; Wang RM; Smith DM; Ghatei MA; Bloom SR
J Endocrinol; 2000 May; 165(2):509-18. PubMed ID: 10810315
[TBL] [Abstract][Full Text] [Related]
18. Effects of c-MYC activation on glucose stimulus-secretion coupling events in mouse pancreatic islets.
Pascal SM; Guiot Y; Pelengaris S; Khan M; Jonas JC
Am J Physiol Endocrinol Metab; 2008 Jul; 295(1):E92-102. PubMed ID: 18413670
[TBL] [Abstract][Full Text] [Related]
19. Gene expression regulated by pioglitazone and exenatide in normal and diabetic rat islets exposed to lipotoxicity.
Ghanaat-Pour H; Sjöholm A
Diabetes Metab Res Rev; 2009 Feb; 25(2):163-84. PubMed ID: 19065603
[TBL] [Abstract][Full Text] [Related]
20. Effect of glimepiride on the electrical activity of isolated rabbit heart muscle.
Ballagi-Pordány G; Németh M; Aranyi Z; Kékesi E; Koltai MZ; Papp G; Pogátsa G
Arzneimittelforschung; 1992 Feb; 42(2):111-3. PubMed ID: 1610416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
